Cargando…
Multiple Components of Protein Homeostasis Pathway Can Be Targeted to Produce Drug Synergies with VCP Inhibitors in Ovarian Cancer
SIMPLE SUMMARY: The increased dependency of cancer cells on protein homeostasis creates a vulnerability that can be exploited using protein homeostasis inhibiting drugs. Recently, valosin-containing protein has emerged as a key component of the pathway and a novel therapeutic target for cancer treat...
Autores principales: | Bastola, Prabhakar, Leiserowitz, Gary S., Chien, Jeremy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9220887/ https://www.ncbi.nlm.nih.gov/pubmed/35740614 http://dx.doi.org/10.3390/cancers14122949 |
Ejemplares similares
-
Co-selected mutations in VCP: a novel mechanism of resistance to VCP inhibitors
por: Bastola, Prabhakar, et al.
Publicado: (2018) -
Heterozygous mutations in valosin-containing protein (VCP) and resistance to VCP inhibitors
por: Bastola, Prabhakar, et al.
Publicado: (2019) -
Specific mutations in the D1–D2 linker region of VCP/p97 enhance ATPase activity and confer resistance to VCP inhibitors
por: Bastola, Prabhakar, et al.
Publicado: (2017) -
The functional importance of VCP to maintaining cellular protein homeostasis
por: Ahlstedt, Brittany A., et al.
Publicado: (2022) -
Ter94/VCP Is a Novel Component Involved in BMP Signaling
por: Zeng, Zhao, et al.
Publicado: (2014)